Aimmune Therapeutics Announces COO Howard Raff To Be Replaced

By: via Benzinga
Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing desensitization treatments for food allergies, today ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.